Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio.
Source link
Neurocrine to Buy Soleno for $2.9 Billion
Date:
More like thisRelated
U.S. and Iran receive 45-day ceasefire proposal
IE 11 is not supported. For an optimal experience...
Santa Fe offering alerts to prepare for wildfire season
JUST WEREN’T RIGHT. THE GOAL OF THE BURN IS...
AI-driven email personalization strategies that actually work
Email personalization drives measurable revenue impact. According to HubSpot’s...
Man Cheats on His Wife Causing Old Kenny Chesney Song Going Viral
It's been 17 years since the release of Kenny...